Coffees Contain 1.25 Mg or 5 Mg of CBD Per Cup
GLENDALE, COLORADO, USA, September 21, 2017 /EINPresswire.com/ — Alexa’s Botanicals, creator of a growing family of phytoCannaBinoiD™ centric products, today announced the addition of two full-spectrum hemp oil infused coffees to its product line; “Gabriela”, which provides 1.25 mg of CBD per cup and “Paolo” which delivers 5 mg of CBD per cup.
These, along with all of Alexa’s Botanicals products, are available at the Company’s website, www.alexasbotanicals.com.
Responsibly sourced from select farms, Alexa's expert roasters secure only specialty-grade Columbian Arabica beans, which they hand-roast to draw out the flavor notes of each bean. Once the perfect balance of acidity, body, and flavor are achieved, the beans are infused with organically derived, full-spectrum, CBD-rich hemp oil. The result is a delicious cup of coffee that delivers a consistent dose of CBD with every cup, providing customers with the full array of cannabinoids, essential vitamins and minerals, fatty acids, protein, chlorophyll, fiber, flavonoids, and terpenes found in the hemp plant.
Alexa’s Botanicals whole-bean coffee is sold in 8-ounce packages, providing 16 servings based on the recommended 1/2 ounce of beans per brewed cup. Customers can choose between two strengths; Paolo, with 80 mg of CBD per bag, 5 mg per serving, and Gabriela, with 1.25 mg of CBD per package, 1.25 mg per serving.
About CBD and the Endocannabinoid System
Cannabinioid receptors are found in almost every organ of the body, including the skin, digestive tract, and reproductive organs, with heavy concentrations in the central nervous system. Cumulatively these receptors are referred to as the Endocannabinoid System (ECS). Although researchers are just beginning to understand the functionality of the ECS, it appears to have some influence in a number of bodily functions, including: mood, memory, motor control, immune function, reproduction, pain perception, appetite, sleep and bone development.
Cannabidiol (CBD) is one of the most prevalent chemical compounds found throughout the cannabis plant. Unlike tetrahydrocannabinol (THC), CBD is not psychoactive, but it is increasingly believed to provide significant health benefits and therapeutic effect. Industrial hemp is a variety of the cannabis plant which, by definition, comprises less than 0.3% THC, making it a particularly rich source of CBD.
Because the cannabinoids secreted by the cannabis flower mimic those produced in the body, they are able to communicate with and activate endocannabinoid receptors to cause a response within the body. Preclinical trials have been and/or are currently being conducted with regard to its impact as an: anti-inflammatory, antioxidant, neuroprotectant, anxiolytic, antidepressant, analgesic, anti-tumoral agent and an anti-psychotic.
About Alexa’s Botanicals
Founded in 2016, Alexa’s Botanicals harnesses the power of phytoCannaBinoiDs™ to create products that support your best health and wellness. All of our products are hand-made in small batches to our own fully-tested formulations, using only carefully selected, natural and organic ingredients.
For more information, visit www.alexasbotanicals.com, follow us on Facebook and Instagram, or call us at 800-838-9124.
INTIVA Disclosure Notice: This press release contains “forward-looking statements” as that term is defined in the Private Securities Litigation Reform Act of 1995. For this purpose, any statements contained herein or which are otherwise made by or on behalf of the Company that are not statements of historical facts may be deemed forward-looking statements. Without limiting the generality of the foregoing, words such as “may,” “will,” “to,” “plan,” “expect,” “believe,” “anticipate,” “intend,” “could,” “should,” “would,” “estimate,” or “continue,” or the negative or other variations thereof or comparable terminology are intended to identify forward-looking statements. Readers are cautioned that all forward-looking statements involve risk and uncertainties which may cause results to differ materially from those set forth in the statements. Such risks and uncertainties include, but are not limited to the following: the success of research and development activities and the speed with which regulatory authorizations and product launches may be achieved; government regulation generally; competitive developments; the ability to successfully market products domestically and internationally; difficulties or delays in manufacturing or issues relating to manufacturing capacity; commercial obstacles to the successful introduction of brand products generally; legal defense costs, insurance expenses, settlement costs, and the risk of an adverse decision or settlement relating to product liability, patent protection, governmental investigations, and other legal proceedings; the Company’s ability to acquire and protect patents and other intellectual property both domestically and internationally; the absence of certainty regarding the receipt of required regulatory approval or the timing or terms of such approvals; any changes in business, political and economic conditions; business interruption due to hurricanes or other events outside of the Company’s control.
Readers are cautioned not to place reliance on these forward-looking statements, which are valid only as of the date they were made. The Company undertakes no obligation to update or revise any forward-looking statements to reflect new information or the occurrence of unanticipated events or otherwise, except as expressly required by law.
email us here
Source: EIN Presswire